Skip to main content
. 2016 May 10;20(3):126–132. doi: 10.1080/13651501.2016.1179765

Table 2.

Baseline characteristics of patients with moderate depression treated with WS® 5570 3 × 300 mg/d or paroxetine [mean (SD) or absolute frequency (percent) of patients and two-sided p value; pooled data; FAS, LOCF].

  WS® 5570 3 × 300 mg/d (n = 31) Paroxetine 20 mg/d (n = 33) p Value (test)
HAM-D Score mean (SD) 23.1 (0.9) 22.9 (0.8) 0.248 (t-test)
Age (years) mean (SD) 48.6 (11.9) 42.9 (11.6) 0.056 (t-test)
Duration of current episodes (days) mean (SD) 165 (153) 121 (88) 0.178 (t-test)
No. of women n (%) 21 (67.7) 18 (54.6) 0.280 (χ2-test)
No. of patients with recurrent depression n (%) 13 (41.9) 19 (57.6) 0.211 (χ2-test)